4Smith CM, Smith WC. Chemoprophylaxis is effective in the prevention of leprosy in endemic countries: a systematic review and meta- analysis . MILEP2 Study Group. Mucosal Immunology of Leprosy[J] . J. infect, 2000,41 (2) : 137-142.
5Dieltto C . Elimination of leprosy in the Federated States of Micronesia by intensive case finding,treatment with WHO/MDT and administration of chemoprophylaxis [J]. Int. J. Lepr, 1999,67: 4Suppl. S10-S13.
6Nguyen LN, Cartel JL, Grosset JH, et al. Chemoprophylaxis of leprosy in the southern Marquesas with a singly 25 mg/kg doses of rifampicin. Results after 10 years[J]. Lepr. Rev,2000,71: Suppl: S33-35.
7Vijayakumaran P,Krishnamurthy P,Rao P,et al. Chemoprophylaxis against leprosy: expectations and methodology of a trial[J]. Lepr Rev. 2000,71 Suppl:S37-40; discussion S40-1.
8Bakker MI, Hatta M,Kwenang A,et al . Prevention of leprosy using rifampicin as chemoprophylaxis. Am[J] . J. Trop. Med. Hyg,2005,72: 443-448.
9Moet FJ,Pahan D,Oskam L,et al . Effectiveness of single dose rifampicin in preventing leprosy in close contacts of patients with newly diagnosed leprosy: cluster randomised controlled trial [J] . COLEP Study Group. BMJ,2008,336(7647) : 761-764.
10Moet FJ,Oskam L,Faber R,et al. A study on transmission and a trial of chemoprophylaxis in contacts of leprosy patients: design, methodology and recruitment findings of COLEP [J] . Lepr Rev, 2004,75(4):376-388.
4WHO Leprosy Unit.Risk of relapse in leprosy[J].Indian J Lepr,1995,67(1):13-26.
5JAMET P,JI B.Relapse after long-term follow up of multibacillary patients treated by WHO Multidrug Regimen Marchoux Chemotherapy Study Group[J].hat J Lepr Other Mycobat Dis,1995,63(2):195-201.
6GIRDHAR BK,GIRDHAR A.KUMAR A.Relapses in maltibacillary leprosy patients:effect of length of therapy[J].Lepr Rev,2000,71(2):144-153.
